ACADIA PHARMACEUTICALS INC·4

Oct 16, 5:30 PM ET

Ndu Adora 4

4 · ACADIA PHARMACEUTICALS INC · Filed Oct 16, 2023

Insider Transaction Report

Form 4
Period: 2023-10-12
Ndu Adora
Director
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2023-10-124,3814,381 total
    Common Stock (4,381 underlying)
  • Exercise/Conversion

    Common Stock

    2023-10-12+4,3814,381 total
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
  • [F2]The restricted stock units shall vest in two equal annual installments commencing on the first anniversary of the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION